Table 1.
TNFAIP2 expression in select lymphomas
| Tumor Type | # Tested | # Positive | % Positive |
|---|---|---|---|
| Follicular dendritic cell sarcoma | 4 | 4 | 100 |
| Histiocytic sarcoma | 3 | 3 | 100 |
| Hodgkin lymphoma | |||
| Classical Hodgkin lymphoma | 31 | 31 | 100 |
| Nodular lymphocyte predominant Hodgkin lymphoma | 12 | 12 | 100 |
| DLBCL | |||
| Not otherwise specified | 45 | 2 | 4 |
| Mediastinal (thymic) large B cell lymphoma | 31 | 27 | 87 |
| T-cell/histiocyte rich large B cell lymphoma | 3 | 3 | 100 |
| Unclassifiable, int. DLBCL and Burkitt lymphoma | 4 | 0 | 0 |
| Burkitt lymphoma | 18 | 2 | 11 |
| Anaplastic large cell lymphoma | 19 | 1 | 5 |
| Additional B-cell neoplasms | |||
| Follicular lymphoma | 18 | 0 | 0 |
| Mantle cell lymphoma | 13 | 1 | 8 |
| Extranodal marginal zone lymphoma | 14 | 1 | 7 |
| Small lymphocytic lymphoma | 8 | 0 | 0 |
| B lymphoblastic leukemia/lymphoma | 13 | 2 | 15 |
| Additional T- and NK-cell neoplasms | |||
| Angioimmunoblastic T-cell lymphoma | 7 | 1 | 14 |
| Peripheral T-cell lymphoma, NOS | 10 | 2 | 20 |
| Extranodal NK/T-cell lymphoma, nasal type | 5 | 1 | 20 |
| T lymphoblastic leukemia/lymphoma | 10 | 3 | 30 |